Trulieve Cannabis (TRLV) Non Operating Interest Expenses (2020 - 2026)

Trulieve Cannabis has reported Non Operating Interest Expenses for 7 years, with the latest figure at $12.8 million in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses fell 22.16% year-over-year to $12.8 million in Q2 2026; TTM through Jun 2026 was $56.8 million, a 12.22% decrease from a year earlier, with the FY2025 full-year figure at $63.5 million, up 2.03% from the prior year.
• Non Operating Interest Expenses was $12.8 million for Q2 2026 at Trulieve Cannabis, down from $13.3 million in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $21.2 million in Q4 2022, with the low at $12.8 million in Q2 2026.
• Average Non Operating Interest Expenses over 5 years is $17.1 million, with a median of $16.9 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Non Operating Interest Expenses jumped 188.54% in 2022, then sank 30.68% in 2024.
• Over 5 years, Non Operating Interest Expenses stood at $21.2 million in 2022, then dropped by 2.59% to $20.6 million in 2023, then dropped by 29.2% to $14.6 million in 2024, then rose by 0.43% to $14.7 million in 2025, then declined by 13.07% to $12.8 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $12.8 million (Q2 2026), $13.3 million (Q1 2026), and $14.7 million (Q4 2025), per Business Quant data.